Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2023 10:35 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Participate in the 35th Annual Roth Conference

SAINT LAURENT, Quebec, March 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, will be participating...
February 21, 2023 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent

SAINT LAURENT, Quebec, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that the United...
February 09, 2023 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Research Collaboration with Renowned Neurologist to Evaluate Montelukast VersaFilm® for the Treatment of Parkinson’s Disease

SAINT-LAURENT, Quebec, Feb. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced a research...
January 23, 2023 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx and Arwan Enter into a Supply Agreement for RIZAPORT® in MENA Countries

SAINT LAURENT, Quebec, Jan. 23, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, announced today that it has entered...
January 09, 2023 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives Fourth and Final Loan Tranche from atai

SAINT LAURENT, Quebec, Jan. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company”) today announced that its wholly-owned subsidiary, IntelGenx Corp....
December 07, 2022 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Collaboration with UPEI to Evaluate Acceptance and Preference of VetaFilm™ Platform in Dogs and Cats

SAINT LAURENT, Quebec, Dec. 07, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced a research...
November 22, 2022 07:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives FDA PDUFA Date for RIZAFILM®

SAINT LAURENT, Quebec, Nov. 22, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the U.S. Food...
November 10, 2022 17:55 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reschedules Third Quarter 2022 Conference Call Due to Technical Issues Experienced Today by Webcast Vendor

SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that its third quarter...
November 10, 2022 16:05 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Third Quarter 2022 Financial Results

SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter...
November 09, 2022 07:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm™

SAINT LAURENT, Quebec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that it has entered...